Clinical trialNCT06510361RecruitingPhase 2Interventional

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

SponsorBeth Israel Deaconess Medical CenterEnrollment35Follicular LymphomaLymphomaLymphoma, Non-Hodgkin's, AdultLymphoma,Non-Hodgkin

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This research is being done to see if epcoritamab is effective in treating follicular lymphoma as a second line of treatment. The name of the study drug in this research study is: -Epcoritamab (a type of antibody)

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Gottfried von Keudell, MD, PhD
Beth Israel Deaconess Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Stanford
Stanford, California, United States
Joseph Schroers-Martin, MD
Recruiting
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Gottfried von Keudell, MD PhD
Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Joshua Brody, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Epcoritamab →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 20 Nov 2024
Primary completion: 1 May 2026
Completion: 1 May 2028
Last update posted: 13 Mar 2026
Registered enrollment: 35
Registry id: NCT06510361

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.